Dupilumab is a medication used to treat asthma and atopic dermatitis. It is a monoclonal antibody that works by targeting the protein interleukin-4 (IL-4). Dupilumab was first approved for use in the United States in 2014, and it is marketed under the brand name Dupixent.
Dupilumab is typically used when other medications have not been effective in treating asthma or atopic dermatitis. It may be used as either an inhaled form for treating asthma or as an injection for treating atopic dermatitis. The injectable form of dupilumab should only be given by a healthcare provider.
Common side effects of dupilumab include cold sores, upper respiratory tract infection, headache, diarrhea, nausea, and pain at the injection site. More serious side effects are also possible with this medication; however, they are rare. These include hypersensitivity reactions, such as hives Âand facial swelling. As with any medication, patients should speak to their doctor about all potential risks and benefits prior to beginning treatment.
Read more about dupilumab